- — Diversity & Inclusion
Science That Reflects Every Patient
At CenExel, diversity is the foundation of clinical excellence. When trials reflect the real world, better science follows — and every patient benefits from the therapies we help bring to life.
Years of Experience
0
+
Centers of Excellence
0
+
Inpatient Beds
0
+
Enrollment Target Met
0
%
— Our Foundation
Committed to Diversity in Clinical Research
CenExel Clinical Research believes that equitable representation in clinical trials is not just the right thing to do — it is critical to advancing medical science. Our 18 research centers are strategically located in diverse urban communities across the United States.
Strategically located in diverse US metropolitan areas to reach underrepresented communities
Bilingual research teams and multilingual patient materials available across our network
Culturally competent care models developed with community health partners
Dedicated Diversity Task Forces embedded within every therapeutic area
Patient navigation programs that remove barriers to participation
Our Framework
Three Pillars of Our D&I Strategy
Every initiative we run is grounded in a clear framework: reach, engage, and sustain — ensuring diversity goes beyond enrollment numbers.
Reach Underserved Communities
Our site locations, community partnerships, and targeted outreach programs ensure clinical trials reach populations that have historically been excluded from research.
Engage with Cultural Competence
From multilingual study teams to culturally tailored consent processes, we design every participant touchpoint to be welcoming, respectful, and inclusive.
Sustain Long-Term Relationships
We build trust through ongoing community investment, transparent data reporting, and programs that return value to the communities who participate in our research.
By The Numbers
Representation Across Our Network
Our network actively enrolls participants from all backgrounds. Here is how our patient population reflects the diversity of the communities we serve.
Hispanic / Latino Participants
38%
of enrolled participants across the network
Black / African American Participants
27%
enrolled in Central Nervous System trials
Asian & Pacific Islander Participants
18%
participating in ethnic bridging studies
Female Participants
54%
women enrolled across all therapeutic areas
“Diverse clinical trials are not a box to check — they are the only way to develop medicines that truly work for everyone. CenExel has built a network where inclusive enrollment is simply how we operate.”